Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) Antibodies:
anti-Rat (Rattus) Antibodies:
Go to our pre-filtered search.
Human Monoclonal HPSE Primary Antibody for ICC, FACS - ABIN438793
Dorrell, Abraham, Lanxon-Cookson, Canaday, Streeter, Grompe: Isolation of major pancreatic cell types and long-term culture-initiating cells using novel human surface markers. in Stem cell research 2009
Show all 3 Pubmed References
Human Polyclonal HPSE Primary Antibody for WB - ABIN3043707
Tang, Zhang, Zhao, Wang, Lu, Song, Zhao, Kang, Wang, Xu, Tian: The expression and clinical significance of microRNA-1258 and heparanase in human breast cancer. in Clinical biochemistry 2013
Show all 2 Pubmed References
Human Polyclonal HPSE Primary Antibody for WB - ABIN3042457
Tang, Piao, Zhao, Mu, Li, Ma, Song, Wang, Zhao, Zhang: Expression and correlation of matrix metalloproteinase-9 and heparanase in patients with breast cancer. in Medical oncology (Northwood, London, England) 2014
Show all 2 Pubmed References
Plasma heparanase is not significantly associated with urinary microalbumin/creatinine, while it is correlated positively with blood glucose levels in the early stage of diabetic nephropathy
These results demonstrate that Smad4 (show SMAD4 Antibodies) suppresses the tumorigenesis and aggressiveness of neuroblastoma (show ARHGEF16 Antibodies) through repressing the HPSE expression.
Over-expression of circHIPK3 effectively inhibits migration, invasion, and angiogenesis of bladder cancer cells in vitro and suppresses bladder cancer growth and metastasis in vivo Mechanistic studies reveal that circHIPK3 contains two critical binding sites for the microRNA miR (show MLXIP Antibodies)-558 and can abundantly sponge miR (show MLXIP Antibodies)-558 to suppress the expression of heparanase (HPSE).
the results of this study suggest that the use of HPSE as a predictive factor for clinical prognosis and as a treatment target would benefit breast cancer patients.
The results of this study shown the Upregulated Expression of Heparanase in the Brains of Alzheimer's Disease.
Heparanase has a role in upregulating platelet adhesion activity and thrombogenicity
Results show that all tested inhibitors reduced heparanase (HPA) enzyme activity and inhibited the growth of HeLa cells.
Data demonstrate that the mesenchymal features induced by HPSE in MM cells contribute to enhanced tumor cell motility and bone-dissemination.
c-Myc (show MYC Antibodies) and heparanase expression was positively correlated with hTERT levels, and was also an independent predictor of metastasis and survival.
miR (show MLXIP Antibodies)-558 facilitates the progression of gastric cancer through directly targeting the HPSE promoter to attenuate Smad4 (show SMAD4 Antibodies)-mediated repression of HPSE expression.
Study reveals that HPSE stimulates the proliferation of ES cells as well as the expansion of emerging progenitors during neural differentiation.
heparanase as a key mediator of macrophage activation and function in tumorigenesis and cross-talk with the tumor microenvironment.
Results demonstrate that acute ischemic injury up-regulates renal heparanase expression and suggest that heparanase plays a deleterious role in the development of renal injury and kidney dysfunction.
eNOS (show NOS3 Antibodies) prevents heparanase induction and the development of proteinuria
Data show that heparanase-1 (HPA-1) induced shedding of heparan sulfate chain from syndecan-1 (SDC-1 (show SDC1 Antibodies)) facilitated the release of vascular endothelial growth factor C (VEGF-C (show VEGFC Antibodies)) from SDC-1 (show SDC1 Antibodies)/VEGF-C (show VEGFC Antibodies) complex into the medium of hepatocarcinoma cell.
the activation of intestinal heparanase contributes to intestinal injury during early sepsis by facilitating the destruction of mucosal epithelial glycocalyx and promoting inflammatory responses.
Heparanase increases the inflammation in AGEs-stimulated macrophages through activating the RAGE (show AGER Antibodies)-NF-kappaB (show NFKB1 Antibodies) pathway. Heparanase driven inflammation from AGEs-stimulated macrophages increases the adherence of glomerular endothelial cells (GEnCs) and augments the permeability of GEnCs.
heparanase contributes to allergen-induced eosinophil recruitment to the lung.
Unfractionated heparin inhibits heparanase, and reverses the activation of NF-kappaB (show NFKB1 Antibodies) and MAPK P38 (show MAPK1 Antibodies) signaling pathways to attenuate inflammatory responses induced by sepsis. These results suggest that UFH
These data suggest that porcine reproductive and respiratory syndrome virus activates NF-kappaB (show NFKB1 Antibodies) and cathepsin L to upregulate and process heparanase, and then the active heparanase cleaves heparan sulfate, resulting in viral release.
during late gestation, the mRNA and HPSE levels were higher in Meishan placentae than Yorkshire pigs
study of tissue expression profiles, polymorphisms of HPSE and HPSE2 (show HPSE2 Antibodies) genes and changes of their mRNA levels in porcine alveolar macrophages (PAMs) induced by PRRSV; upon stimulation in healthy piglets with PRRSV, HPSE mRNA was obviously upregulated, while HPSE2 (show HPSE2 Antibodies) mRNA did not induce a prominent change in PAMs
our results support a critical role for heparanase in the development of vulnerable atherosclerotic plaques
report molecular cloning and characterisation of heparanase mRNA in the porcine placenta throughout gestation.
Suggest that high glucose is a potent stimulator of endothelial heparanase secretion.
Lutropin (show LHB Antibodies) induces a transient increase in HPSE mRNA at specific times after its addition.
Heparan sulfate proteoglycans are major components of the basement membrane and extracellular matrix. The protein encoded by this gene is an enzyme that cleaves heparan sulfate proteoglycans to permit cell movement through remodeling of the extracellular matrix. In addition, this cleavage can release bioactive molecules from the extracellular matrix. Several transcript variants encoding different isoforms have been found for this gene.
, endoglycosidase heparanase